ea0035oc1.3 | Thyroid clinical | ECE2014
Holmager Pernille
, Schmidt Ulla
, Dall Mark Peter
, Dominguez Helena
, Zerahn Bo
, Raymond Ilan
, Kistorp Caroline
, Nygaard Birte
, Faber Jens
Background and aim: Low T3 syndrome is associated with a poor prognosis in patients with chronic heart failure (CHF). It is controversial whether T3 treatment is indicated in CHF. A previous study using intravenous infusion of T3 for 72 h suggested a beneficial effect on cardiac performance.We aimed to evaluate the effect of 13 weeks of T3 treatment in patients with stable CHF on left ventricular ejection fraction (LVEF) compared to placebo.<p class=...